-- Novel cell therapy company launched out of Versant’s Ridgeline Discovery Engine -- -- Cimeio developing Shielded-Cell & Immunotherapy Pairs aimed at revolutionizing cell therapeutics -- -- Applications in rare genetic diseases, hematologic mal
Topical formulation of paromomycin ATI-1801 already shown to be safe and effective against the disfiguring disease in Phase 3 study ATI-1801 may be eligible for tropical disease priority review voucher if approved by FDA HALIFAX, Nova Scotia--(BUSINESS
The premium craft brand arrives with flower, vapes and concentrates available for purchase ahead of 420 CHICAGO--(BUSINESS WIRE)--Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), a vertically integrated multistate operator and the
– JIXING to lead development and commercialization of LNZ100 and LNZ101 in Greater China – – LENZ to receive up to $110 million in upfront and milestone payments, as well as royalty payments based on future net sales – – RTW to invest $10 mil
WINNIPEG, Manitoba--(BUSINESS WIRE)--$FDGE #AgTech--Farmers Edge Inc. (“Farmers Edge” or the “Company”) (TSX: FDGE), a global leader in digital agriculture, today announced Maple Leaf Foods Inc.’s (“Maple Leaf Foods”) purchase of certified r
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan & LONDON--(BUSINESS WIRE)--Gensource Potash Corporation (“Gensource” or the “Company”) (TSXV: GSP, AIM: GSP), a fertilizer development c
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Compass Minerals (NYSE: CMP), a leading global provider of essential minerals, today announced it has received an earnout payment of approximately R$88 million, or $18.5 million based on current exchange rates, associ
VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) will announce its first quarter 2022 financial results on Tuesday, May 10, 2022, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same
A revolutionary device that treats Atrial Fibrillation (AF) – the world's most common heart rhythm disorder – helps support the healthy aging of BC's population. VANCOUVER, British Columbia--(BUSINESS WIRE)--Kardium Inc. announces a successful first-
VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.